BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
0.2782
-0.0066 (-2.32%)
At close: Mar 11, 2026, 4:00 PM EDT
0.2529
-0.0253 (-9.09%)
After-hours: Mar 11, 2026, 7:59 PM EDT
BioRestorative Therapies Employees
BioRestorative Therapies had 11 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
11
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$34,855
Profits / Employee
-$1,151,862
Market Cap
5.96M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 11 | 0 | - | 11 | 0 |
| Dec 31, 2023 | 11 | 1 | 10.00% | 11 | 0 |
| Dec 31, 2022 | 10 | 3 | 42.86% | 10 | 0 |
| Dec 31, 2021 | 7 | 2 | 40.00% | 7 | 0 |
| Dec 31, 2020 | 5 | -1 | -16.67% | 5 | 0 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 117 |
| Quince Therapeutics | 36 |
| XTL Biopharmaceuticals | 10 |
| Processa Pharmaceuticals | 10 |
| Purple Biotech | 9 |
| Aprea Therapeutics | 8 |
| Xenetic Biosciences | 2 |
| Aptorum Group | 1 |
BRTX News
- 6 days ago - BioRestorative Therapies, Inc. to Participate in the Be+Well Beauty and Wellness Show in New York City, March 8-10, 2026 - GlobeNewsWire
- 15 days ago - BioRestorative Expands Global Protection for ThermoStem®, a Potentially Longer-Lasting and Safer Cell-Based Alternative to GLP-1 Drugs - GlobeNewsWire
- 26 days ago - BioRestorative Announces Closing of $5.0 Million Public Offering - GlobeNewsWire
- 4 weeks ago - BioRestorative Announces Pricing of $5.0 Million Public Offering - GlobeNewsWire
- 4 weeks ago - BioRestorative Announces Positive Outcome from Type B Meeting with FDA - GlobeNewsWire
- 4 months ago - BioRestorative Therapies, Inc. (BRTX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - BioRestorative Therapies to Report Third Quarter 2025 Financial Results and Host Conference Call on November 12, 2025 - GlobeNewsWire
- 4 months ago - BioRestorative Awarded Notice of Allowance for Japanese Patent – Expands Protection for Potential Cell-Based Alternative to Multi-Billion Dollar GLP-1 Drug Market - GlobeNewsWire